论文部分内容阅读
目的:分析阿奇霉素在妇科支原体感染临床治疗中的用药情况及其临床疗效。方法:资料选取本院2015年3月-2016年3月收治的妇科支原体感染患者共104例,按照不同治疗方法分为研究组与对照组;研究组52例予口服阿奇霉素,对照组52例予注射阿奇霉素;观察治疗后两组患者的心理状况与心理症状自评量表评估结果。结果:治疗后研究组患者临床疗效显著显著高于对照组患者,比较差异明显具统计学意义(P<0.05);治疗后研究组不良反应发生率显著低于对照组患者,比较差异明显具统计学意义(P<0.05)。结论:口服阿奇霉素治疗妇科支原体感染的临床效果优于采用注射阿奇霉素,且临床安全性较高,故建议妇科支原体感染采用口服阿奇霉素治疗。
Objective: To analyze the use of azithromycin in the clinical treatment of gynecological mycoplasma infection and its clinical efficacy. Materials and Methods: A total of 104 patients with mycoplasma genitalium infection were selected from March 2015 to March 2016 in our hospital. The patients were divided into study group and control group according to different treatment methods. In the study group, 52 patients were given oral azithromycin and the control group was given 52 cases Injection of azithromycin; observed two groups of patients after treatment, psychological status and psychological symptoms self-rating scale assessment results. Results: After treatment, the clinical efficacy of the study group was significantly higher than that of the control group, the difference was statistically significant (P <0.05); after treatment, the incidence of adverse reactions in the study group was significantly lower than the control group, the difference was statistically significant Significance (P <0.05). Conclusion: The clinical efficacy of oral azithromycin in the treatment of gynecological mycoplasma infection is better than the injection of azithromycin, and high clinical safety, it is recommended oral mycoplasma infection azithromycin treatment.